- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type II Diabetes in South Africa
Total 4219 results
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Clemson UniversityUniversity of California, Los Angeles; Prisma Health-UpstateCompletedQuality of Life | Diabetes | Stress | Health Behavior | Pre-DiabetesUnited States
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Bristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Canada, Australia, United States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Romania, United Kingdom, Spain, Mexico, Austria, South Africa, Germany, Ukraine, India
-
The Medicines CompanyCompletedElevated Cholesterol | Heterozygous Familial HypercholesterolemiaUnited States, Canada, Czechia, Denmark, Netherlands, South Africa, Spain, Sweden
-
Clínica Los YosesNovo Nordisk A/SCompletedDiabetes Mellitus, Type 2Costa Rica, El Salvador, Guatemala, Honduras
-
Integra LifeSciences CorporationIntegriumTerminatedDiabetic Foot UlcersUnited States, Puerto Rico, Canada, South Africa
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, United States, Estonia, Mexico, South Africa, Taiwan, Russian Federation, Canada, Slovakia, United Kingdom, Malaysia, Thailand, Australia, Hungary, Bulgaria, Brazil, Germany, Lithuania, Denmark, Romania, Ukraine, Poland, India, Israe... and more
-
Garvan Institute of Medical ResearchCompleted
-
Cardiff and Vale University Health BoardCompletedSepsis | Acute Kidney Injury | Diabetic KetoacidosisUnited Kingdom
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Greater Houston Retina ResearchRegeneron Pharmaceuticals; Clinical Trials Resource Group, LLCActive, not recruitingDiabetic RetinopathyUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Dominican Republic, Chile
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Germany, Mexico, Romania, Serbia, South Africa, Ukraine, Chile, Peru, Puerto Rico, Austria, Hungary, Slovakia, India, Czechia, Latvia, Argentina, United Kingdom
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States
-
University of South CarolinaActive, not recruitingOverweight and Obesity | Type2 DiabetesUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
GlaxoSmithKlineCompletedRetinopathy, DiabeticAustralia, Netherlands, Italy, Germany, Denmark
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Hungary
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, United States, Australia, Hungary, Poland, Romania, Spain
-
Helixmith Co., Ltd.RecruitingDiabetic Peripheral NeuropathyUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Solvay PharmaceuticalsCompletedType 2 Diabetes | HypogonadismUnited States
-
Daiichi Sankyo, Inc.Completed
-
University of AdelaideSalk Institute for Biological StudiesTerminatedInsulin Resistance | Type2 DiabetesAustralia
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
BioDelivery Sciences InternationalCompletedNeuropathy | Painful Diabetic Neuropathy | Diabetic NeuropathyUnited States
-
Arcion Therapeutics IncCompletedPainful Diabetic NeuropathyUnited States
-
EyePoint Pharmaceuticals, Inc.RecruitingNonproliferative Diabetic RetinopathyUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusPuerto Rico, United States, Poland, Slovakia
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
NeuroBo Pharmaceuticals Inc.Dong-A ST Co., Ltd.Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, United Kingdom, Ireland, France, South Africa, Ukraine
-
Novartis PharmaceuticalsTerminatedPainful Diabetic NeuropathyBelgium, Austria, Germany, Australia, United Kingdom, Bulgaria, Slovakia, Hungary, Spain, Portugal, France, Poland, Denmark, Norway, Canada, Finland
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Mexico, Japan, India, Puerto Rico, China
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Puerto Rico, Mexico